首页> 外国专利> Herbal medicament, e.g. for treating sickle cell anemia or AIDS, containing extracts of Fagara xanthoxyloides and Securidaca longepedunculata and/or Uvaria chamae

Herbal medicament, e.g. for treating sickle cell anemia or AIDS, containing extracts of Fagara xanthoxyloides and Securidaca longepedunculata and/or Uvaria chamae

机译:草药,例如用于治疗镰状细胞性贫血或艾滋病,其包含Fagara xanthoxyloides和Securidaca longepedunculata和/或Uvaria chamae的提取物

摘要

A composition (A) containing an extract of the plant Fagara xanthyloxyloides additionally contains an extract of the plant Securidaca longepedonculata and/or Uvaria chamae, is new. ACTIVITY : Cardiant; antiarrhythmic; hypotensive; antisickling; vasotropic; antidiabetic; cerebroprotective; immunostimulant; anti-HIV; anticoagulant; neuroprotective; nootropic. In clinical tests in a group of 170 sickle cell anemia patients (aged 1-30 years), treatment with 100 mg/kg of a composition of the invention (exact composition not specified), three times daily with meals, eliminated the need for hospitalization and transfusions in 97% of cases in 10 weeks, eliminated icterus in 99% of cases within 3-8 weeks and corrected the anemia in 70% of cases in 3 months. MECHANISM OF ACTION : None given in the source material.
机译:含有植物Fagara xanthyloxyloides的提取物的组合物(A)还含有植物长叶Securidaca longepedonculata和/或美洲豆U的提取物。活动:Cardiant;抗心律不整;低血压抗病促血管抗糖尿病脑保护免疫刺激剂抗艾滋病毒抗凝物;神经保护促智的。在一组170名镰状细胞性贫血患者(年龄1至30岁)的临床试验中,每天三餐,每次100毫克/千克本发明的组合物(确切的组合物未指定)治疗,无需住院在10周内完成97%的病例输血,在3-8周内消除99%的病例的黄疸,并在3个月内纠正70%的病例的贫血。作用机理:原始材料中没有给出。

著录项

  • 公开/公告号FR2855055A1

    专利类型

  • 公开/公告日2004-11-26

    原文格式PDF

  • 申请/专利权人 MEDEGAN FAGLA JEROME;

    申请/专利号FR20020000585

  • 发明设计人 MEDEGAN FAGLA JEROME;

    申请日2002-01-18

  • 分类号A61K35/78;A61P7/00;A61P31/18;

  • 国家 FR

  • 入库时间 2022-08-21 21:58:29

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号